Lad TE - Search Results

1

Personalized Management of Chemotherapy-Induced Peripheral Neuropathy Based on a Patient Reported Outcome: CALGB 40502 (Alliance).

Sharma MR, Mehrotra S, Gray E, Wu K, Barry WT, Hudis C, Winer EP, Lyss AP, Toppmeyer DL, Moreno-Aspitia A, Lad TE, Velasco M, Overmoyer B, Rugo HS, Ratain MJ, Gobburu JV. Sharma MR, et al. Among authors: lad te. J Clin Pharmacol. 2020 Apr;60(4):444-452. doi: 10.1002/jcph.1559. Epub 2019 Dec 4. J Clin Pharmacol. 2020. PMID: 31802506 Free PMC article.

2

Kinetic-Pharmacodynamic Model of Chemotherapy-Induced Peripheral Neuropathy in Patients with Metastatic Breast Cancer Treated with Paclitaxel, Nab-Paclitaxel, or Ixabepilone: CALGB 40502 (Alliance).

Mehrotra S, Sharma MR, Gray E, Wu K, Barry WT, Hudis C, Winer EP, Lyss AP, Toppmeyer DL, Moreno-Aspitia A, Lad TE, Valasco M, Overmoyer B, Rugo H, Ratain MJ, Gobburu JV. Mehrotra S, et al. Among authors: lad te. AAPS J. 2017 Sep;19(5):1411-1423. doi: 10.1208/s12248-017-0101-9. Epub 2017 Jun 15. AAPS J. 2017. PMID: 28620884 Free PMC article. Clinical Trial.

3

Pharmacokinetics and pharmacodynamics of 9-aminocamptothecin infused over 72 hours in phase II studies.

Minami H, Lad TE, Nicholas MK, Vokes EE, Ratain MJ. Minami H, et al. Among authors: lad te. Clin Cancer Res. 1999 Jun;5(6):1325-30. Clin Cancer Res. 1999. PMID: 10389915 Clinical Trial.

4

A phase II study of 9-aminocamptothecin in advanced non-small-cell lung cancer.

Vokes EE, Ansari RH, Masters GA, Hoffman PC, Klepsch A, Ratain MJ, Sciortino DF, Lad TE, Krauss S, Fishkin PA, Golomb HM. Vokes EE, et al. Among authors: lad te. Ann Oncol. 1998 Oct;9(10):1085-90. doi: 10.1023/a:1008432729754. Ann Oncol. 1998. PMID: 9834820 Free article. Clinical Trial.

5

Postsurgical adjuvant therapy in stages I, II, and IIIA non-small cell lung cancer.

Lad TE. Lad TE. Hematol Oncol Clin North Am. 1990 Dec;4(6):1111-9. Hematol Oncol Clin North Am. 1990. PMID: 1962778 Review.

6

Carfilzomib-associated cardiovascular adverse events in a non-Caucasian cohort of patients with multiple myeloma: A real-world experience.

Mangla A, Paydary K, Liu J, Mbachi C, Yim B, Lad TE. Mangla A, et al. Among authors: lad te. Hematol Oncol. 2018 Oct;36(4):715-717. doi: 10.1002/hon.2535. Epub 2018 Aug 3. Hematol Oncol. 2018. PMID: 30074629 No abstract available.

7

Phase II trial of spirogermanium in advanced non-small cell lung cancer. An Illinois Cancer Council Study.

Lad TE, Blough RR, Evrard M, Shevrin DP, Cobleigh MA, Johnson CM, Hange P. Lad TE, et al. Invest New Drugs. 1989 Jul;7(2-3):223-4. doi: 10.1007/BF00170862. Invest New Drugs. 1989. PMID: 2551841

8

Phase II study of amonafide in the treatment of patients with advanced squamous cell carcinoma of the head and the neck. An Illinois Cancer Center study.

Rosen F, Vokes EE, Lad T, Kies M, Wade J 3rd, Kilton LJ, Blough R, French S, Mullane M, Benson AB 3rd. Rosen F, et al. Invest New Drugs. 1995;13(3):249-52. doi: 10.1007/BF00873808. Invest New Drugs. 1995. PMID: 8729954 Clinical Trial.

9

Phase II trial of caracemide (NSC 253272) in advanced unresectable non-small cell bronchogenic carcinoma. An Illinois Cancer Council study.

Lad T, Schor J, Mullane M, Carroll R, Chernicoff D, Blough R, Weidner L. Lad T, et al. Invest New Drugs. 1992 Apr;10(1):27-8. doi: 10.1007/BF01275475. Invest New Drugs. 1992. PMID: 1318870 Clinical Trial. No abstract available.

10

Radiotherapy alone compared with radiotherapy and chemotherapy in patients with squamous cell carcinoma of the esophagus.

Reddy SP, Lad T, Mullane M, Rosen F, Carroll R, Marks JE. Reddy SP, et al. Am J Clin Oncol. 1995 Oct;18(5):376-81. doi: 10.1097/00000421-199510000-00002. Am J Clin Oncol. 1995. PMID: 7572750

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

70 results

Search Page